Birdwatch Archive

Birdwatch Note Rating

2024-04-23 23:57:29 UTC - HELPFUL

Rated by Participant: 270D467521E5A7A0E2FEBCD6FE2BEB3FB9E65DCE0033D209F296B3ED6D9C9BDA
Participant Details

Original Note:

This study is about daily ketamine abusers (2–9.7 years; mean use 2.4 g/day). Esketamine has been approved as a treatment for depression in both the United States and Europe. Low dose ketamine schedules have strong antidepressant effects in depressed patients. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972190/

All Note Details

Original Tweet

All Information

  • noteId - 1780121804884910341
  • participantId -
  • raterParticipantId - 270D467521E5A7A0E2FEBCD6FE2BEB3FB9E65DCE0033D209F296B3ED6D9C9BDA
  • createdAtMillis - 1713916649117
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1780121804884910341270D467521E5A7A0E2FEBCD6FE2BEB3FB9E65DCE0033D209F296B3ED6D9C9BDA